AUS
NZ
UK
CA
USA
IND
Healthcare
Pfizer Inc.Positioned for Success as Economic Trends Shift
October 20, 2024 09:52 AM PDT| By Team Kalkine MediaHeadlines,Pfizer Inc.,(NYSE:PFE),is recognized for its strong return on equity (ROE) among leading stocks.,Shifts in the economic landscape, driven by Federal Reserve rate changes, influence expectations for Pfizer and other stocks.,Morgan Stanley's...
Is CVS Health’s CEO Change a Game-Changer?
October 18, 2024 01:25 PM PDT| By Team Kalkine MediaHighlights,CVS Health Corp announces leadership change, appointing a company veteran as the new CEO.,The company adjusts its profit guidance for the third quarter, citing specific charges impacting earnings.,CVS shares experience a significant declin...
Intuitive Has Released Its Earnings for the Third Quarter
October 18, 2024 03:53 AM PDT| By Team Kalkine MediaHighlights:,Procedure Growth: Worldwide da Vinci procedures increased by 18% year-over-year, indicating a rising adoption of robotic-assisted surgeries.,System Placements: The company placed 379 da Vinci surgical systems in Q3 2024, a significant inc...
Three New U.S. Patents Are Granted to Tenon Medical®
October 18, 2024 03:43 AM PDT| By Team Kalkine MediaHighlights,Tenon Medical® has received the issuance of three new U.S. patents.,These patents enhance the company’s innovative technology portfolio.,The new patents support Tenon Medical’s commitment to advancing healthcare solutions in spinal surgery...
JNJ's Positive Q3 Results Prompt Examination of Stock Opportunities
October 18, 2024 03:34 AM PDT| By Team Kalkine MediaHighlights:,Revenue Growth: Q3 revenue reached $22.5 billion, reflecting a 5.2% year-over-year increase, driven by growth in both the Innovative Medicine and MedTech segments.,Pharmaceutical Performance: The Innovative Medicine segment saw a 4.9% ris...
Insights Into the Future of UnitedHealth Stock Are Offered
October 18, 2024 03:29 AM PDT| By Team Kalkine MediaHighlights:,Revenue Growth: UnitedHealth’s revenue for Q3 reached $100.8 billion, marking a 9% increase year-over-year, driven by sales growth in both the UnitedHealth and Optum segments.,Medical Care Ratio: The medical care ratio stood at 85.2%, hig...
Merck's RSV Jab Is Identified as Having Protective Benefits for Infants
October 18, 2024 02:46 AM PDT| By Team Kalkine MediaHighlights:,Merck & Co Inc's experimental treatment, clesrovimab, has demonstrated positive results in a mid- to late-stage trial for respiratory syncytial virus (RSV).,The treatment showed an over 84% reduction in RSV-related hospitalizations and a...
Can Tonix's Antivirals Boost Military Defense?
October 17, 2024 02:29 PM PDT| By Team Kalkine MediaHighlights,Tonix Pharmaceuticals secures initial payment from the Defense Threat Reduction Agency for antiviral development.,The contract supports research on broad-spectrum antiviral agents targeting military protection.,Tonix utilizes its advanced...
Major themes affecting Intuitive Surgical's Q3 are outlined
October 17, 2024 03:18 AM PDT| By Team Kalkine MediaHighlights,Intuitive Surgical is set to announce its Q3 2024 results on October 17, with projected revenues of $2 billion and adjusted earnings of $1.60 per share.,Continued growth in procedure volume and placements of the da Vinci 5 surgical platfor...
Novavax, Inc. (NASDAQ:NVAX) Shares Tumbled on Wednesday Following Clinical Hold on Flu Combination Vaccine
October 17, 2024 12:24 AM PDT| By Team Kalkine MediaHighlights,Novavax faces a clinical hold following the report of motor neuropathy in a trial participant nearly two years post-vaccination.,Analysts at Jefferies revised their price target for Novavax from $31 to $25 amid increased uncertainty about...
OKYO Pharma Ltd (NASDAQ:OKYO) Begins Patient Recruitment for Phase 2 Trial of OK-101 for Neuropathic Corneal Pain
October 17, 2024 12:18 AM PDT| By Team Kalkine MediaHighlights,The trial aims to address unmet needs in the billion-dollar inflammatory dry eye disease market.,OK-101 is the first targeted treatment for NCP, a condition currently managed only with off-label medications.,The study will evaluate pain re...
Globus Medical Hits New High: Analyst Optimism Grows
October 16, 2024 02:56 PM PDT| By Team Kalkine MediaHeadlines,Globus Medical achieves a significant milestone with its stock reaching a new 52-week high.,Analysts provide optimistic outlooks, with increased price targets and positive ratings.,The company continues to garner attention for its strong pe...
CVS Health Corporation Approaching Dividend Deadline
October 16, 2024 02:23 PM PDT| By Team Kalkine MediaHighlights,CVS Health’s ex-dividend date is approaching this October.,The dividend is well-supported by both profits and cash flow.,CVS Health's earnings have remained stable, offering steady dividends.,CVS Health Corporation, a major player in the,h...
Overview of Pfizer's Q3 2024 Financial Performance Provided
October 16, 2024 02:26 AM PDT| By Team Kalkine MediaHighlights:,Upcoming Earnings Announcement:,Pfizer Inc. is scheduled to report its fiscal Q3 earnings results on Tuesday, October 29, with analysts projecting a profit of $0.62 per share, a significant turnaround from a loss in the same quarter last...
A 10.7% Surge Recorded for NovoCure (NVCR); Future Gains Speculated
October 16, 2024 02:05 AM PDT| By Team Kalkine MediaHighlights:,Significant Stock Surge:,NovoCure's shares rose by 10.7% to $17.78, driven by substantial trading volume following FDA approval of its Optune Lua device for metastatic non-small cell lung cancer.,Upcoming Earnings Report:,The company is p...
Is Zymeworks' Stock Surge Hinting at Future Success?
October 15, 2024 02:12 PM PDT| By Team Kalkine MediaHighlights,Zymeworks Inc. has seen its stock price rise significantly over the past year, despite reporting a decline in revenue, suggesting that market sentiment toward the company's potential has improved.,While Zymeworks has yet to generate profit...
Breakthrough For NeuroSense As ALS Treatment Nears Early Approval
October 15, 2024 02:09 PM PDT| By Team Kalkine MediaHighlights,NeuroSense Therapeutics is advancing its plans to file for early commercialization approval for PrimeC, an ALS treatment, under Health Canada's Notice of Compliance with Conditions (NOC/c) policy, following promising clinical trial results...
FDA Boosts Immuneering’s Pancreatic Cancer Breakthrough
October 15, 2024 02:04 PM PDT| By Team Kalkine MediaHighlights,Immuneering has secured orphan drug designation from the FDA for IMM-1-104, a promising therapy targeting pancreatic cancer, providing the company with regulatory incentives and marketing exclusivity advantages.,The orphan drug designation...
How Will ATAI Revolutionize Mental Health Treatments?
October 15, 2024 12:53 PM PDT| By Team Kalkine MediaHighlights,ATAI Life Sciences, a biopharmaceutical company focused on mental health treatments, is set to participate in the 2024 Maxim Healthcare Virtual Summit, highlighting its commitment to advancing mental health therapies.,The company’s co-CEO,...
Can Johnson & Johnson's Innovations Boost Growth?
October 15, 2024 12:46 PM PDT| By Team Kalkine MediaHighlights,Johnson & Johnson experienced a boost in shares following the release of its third-quarter results, highlighting robust performance across its pharmaceutical and medical devices sectors.,The company received regulatory approvals for key tr...
